Pre-treatment with dual antiplatelet therapy in patients with non-ST-segment elevation acute coronary syndromes undergoing percutaneous coronary intervention
MB Yudi, D Eccleston, N Andrianopoulos, O Farouque, SJ Duffy, A Brennan, C Reid, DJ Clark, AE Ajani
Internal Medicine Journal | WILEY | Published : 2015
Funding: The Melbourne Interventional Group acknowledges funding from Abbott, Astra-Zeneca, Biotronik, Boston Scientific, Bristol-Myers Squibb, Cordis Johnson & Johnson, CSL, Medtronic, MSD, Pfizer, Sanofi-Aventis, Servier, Schering-Plough and The Medicines Company. These companies do not have access to data and do not have the right to review manuscripts or abstracts before publication.